Back to Results
First PageMeta Content
Drugs / Teriparatide / Bisphosphonates / Bone fractures / Osteopathies / Osteoporosis / Alendronic acid / Zoledronic acid / Hypovitaminosis D / Medicine / Eli Lilly and Company / Health


Teriparatide (Forteo) for severe osteoporosis (ter-i-PAR-a-tide) Summary Teriparatide is subsidised on the Pharmaceutical Benefits Scheme for severe established osteoporosis in people at very high risk of fracture who de
Add to Reading List

Document Date: 2012-07-27 21:17:55

Open Document

File Size: 239,24 KB

Share Result on Facebook

Company

Eli Lilly Australia Pty Ltd / Saag KG / /

Country

Australia / /

Currency

BMD / /

IndustryTerm

therapies for osteoporosis / delivery device / multidose delivery device / osteoporosis therapy / /

MedicalCondition

idiopathic osteoporosis / established osteoporosis / headaches / headache / arthralgia / urolithiasis / hyperparathyroidism / primary osteoporosis / severe osteoporosis / nausea / osteosarcoma / bone cancers / vitamin D deficiency / postmenopausal osteoporosis / Paget’s disease / osteoporosis / dizziness / secondary bone cancers / antiresorptive osteoporosis / severe established osteoporosis / /

MedicalTreatment

radiation therapy / drug therapy / /

Organization

Pharmaceutical Benefits Advisory Committee / National Park Service / National Science Foundation / US Food and Drug Administration / Therapeutic Goods Administration / Department of Health / /

Person

Prince / Arch Intern Med / /

Position

general practitioner / Prince / Governor / Bone Miner / consulting physician / /

Product

Forteo / vitamin D / /

Technology

radiation / antibodies / GPS / pdf / /

URL

http /

SocialTag